|
 |
| home > epc > winter 2001 > e-cdm - the next generation of clinical research information management systems |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
The options for truly global clinical data management have been limited in past years. Clinical data management (CDM) systems have tended to be architected around paper data processing; remote data entry (RDE) systems focused on remotely capturing data; and electronic data capture (EDC) systems tended to focus on the centralised storage of remotely captured data.
Electronic clinical data management (e-CDM) systems are likely to be the next generation of systems built around the centralisation of electronically captured information, combined with the accessibility of this information over the Internet.
An electronic medium acting as the source document is an attractive prospect. As such, there is a clear move away from systems that manage the physical tracking of paper (and the discrepancies associated with the disconnected community), towards that of a fully paperless solution where the management focus is on visibility.
e-CDM System Requirements
As any self-respecting software designer should know, a fundamental aspect of software product development is a clear definition of the user requirements. But who are the users?
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Computer Systems Validation in the Pharmaceutical Industry
21-22 April 2010, London, UK
Make sure that you and your company’s knowledge of issues within the CSV arena is the best, attend SMi’s Computer Systems Validation in the Pharmaceutical Industry conference taking place in April next year. Discussing issues such as regulatory aspects to CSV - whether the current guidelines need expanding, reinterpreting or rewriting - CSV in an R&D context, the need for a risk-based approach to CSV and many more, this conference promises to be an unmissable event.
More info >> |
|
 |
News and Press Releases |
 |
BioFocus achieves €1.6 M in payments
BioFocus announced that it has achieved success in its oncology target discovery collaboration with Ortho Biotech Oncology Research & Development, a division of Janssen Pharmaceutica N.V. (Janssen). The success of the program has resulted in €1.6 million in target acceptance payments.
More info >> |
|
|
